TIFFANY BROSH: Open Payments
NPI 1518404235 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 11 payments from 5 companies in 2025. Trend: 2023 $430 · 2024 $602 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $95 |
| Amgen Inc. | 3 | $61 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $14 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: AVEIR, REPATHA, ELIQUIS, JARDIANCE, LEQVIO.
Industry payments across MS — which companies pay providers there.
